Table 2.
Characteristics of baseline tumor burden according to RECIST 1.1
Number of target lesions | |
Median [IQR] | 3.0 [2.0–4.0] |
Number of organs involved | |
Median [IQR] | 2.0 [1.0–3.0] |
Total diameter of target lesions (total BTS) | |
Median [IQR] | 96.5 [55.3–144.7] |
Maximum diameter of target lesions (max BTS) | |
Median [IQR] | 49.1 [34.0–69.8] |
Mean diameter of target lesions | |
Median [IQR] | 34.7 [24.5–45.0] |
Site of largest target lesions, n (%) | |
Primary lesion | 158 (60.1) |
Bone | 21 (8.0) |
Pleura | 19 (7.2) |
Liver | 15 (5.7) |
Intrathoracic lymph node | 11 (4.2) |
Adrenal gland | 10 (3.8) |
Lung (metastasis) | 10 (3.8) |
Extrathoracic lymph node | 5 (1.9) |
Brain | 2 (0.8) |
Other | 12 (4.6) |
RECIST 1.1 Response Evaluation Criteria in Solid Tumors guidelines version 1.1, IQR interquartile range, BTS baseline tumor size